INTECH Investment Management’s iTeos Therapeutics ITOS Stock Holding History

INTECH Investment Management’s Portfolio ITOS Stock Details ITOS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-20,806	Closed	-$207K	–	2456
2025 Q2	$207K	Buy	20,806 +2,466	+13%	+$19.9K	﹤0.01%	2072
2025 Q1	$109K	Buy	18,340 +5,529	+43%	+$40.6K	﹤0.01%	2291
2024 Q4	$98.4K	Sell	12,811 -2,274	-15%	-$19.5K	﹤0.01%	2216
2024 Q3	$154K	Buy	+15,085	New	+$230K	﹤0.01%	1802

Other funds holding ITOS

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

INTECH Investment Management's ITOS Position: Q3 2025 in Review

INTECH Investment Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 20,806 shares — an estimated $207K sold.

INTECH Investment Management first reported a position in ITOS in Q3 2024 and held it in 4 quarters. The position peaked at $207K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

INTECH Investment Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
INTECH Investment Management sold 20,806 iTeos Therapeutics shares in Q3 2025, an estimated $207K.
INTECH Investment Management first reported a position in iTeos Therapeutics in Q3 2024 and held it in 4 quarters.
INTECH Investment Management's iTeos Therapeutics position peaked at $207K in Q2 2025.
1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on INTECH Investment Management's 13F filing for Q3 2025, filed 12 Nov 2025.